Lifeforce has raised $12.0M in total across 1 funding round.
Lifeforce's investors include AirAngels, Bold Capital Partners, Footprint Coalition, Lead Edge Capital, Lever VC, M13, Mucker Capital, Next Ventures, Picus Capital, Seaside Ventures, Sequoia Capital, Serena Ventures.
Lifeforce is a health optimization company offering a clinically integrated platform that combines at-home diagnostic testing, personalized care plans, telehealth consultations with functional medicine doctors, and health coaching to help users improve vitality, reduce longevity risks, and extend lifespan.[1][2][3][5] It serves adults, particularly those in midlife seeking proactive health management, by addressing issues like energy, focus, libido, biological age, and chronic disease risks through data-driven tools like the Lifescore—a single 1-100 metric distilling complex biomarkers into actionable insights.[2][4] The company demonstrates strong growth momentum, raising $12 million in Series A funding in 2023 co-led by M13 and Peterson Ventures, with backing from celebrities like Tony Robbins (co-founder), Serena Williams, Dr. Mark Hyman, and Dr. Fatima Cody Stanford, fueling expansion of diagnostics, data tools, and offerings.[3]
Lifeforce was founded in February 2022 by CEO Dugal Bain-Kim and co-founder Joel Jackson, with high-profile involvement from Tony Robbins and connections via M13 Ventures.[1][2][3] Bain-Kim, who previously served as Vice President of Operational Excellence at Included Health (a telehealth firm serving over five million members), holds an MBA from the University of Cambridge and degrees in Finance, American History, and Political Science from the University of Queensland.[1] The idea emerged from Bain-Kim's introduction to Robbins, Peter Diamandis, and Jackson through M13, where they recognized the potential to merge expertise in health, technology, and business to redefine midlife health using modern science.[1] Early traction came swiftly with celebrity backing and a $12 million Series A round shortly after launch, enabling rapid scaling of its telehealth-based model.[3]
Lifeforce rides the explosive trend of longevity medicine and personalized wellness tech, fueled by rising demand for proactive health amid aging populations and post-pandemic focus on prevention.[1][3][4] Timing is ideal as telehealth matures (building on Bain-Kim's Included Health experience) and biomarkers/data analytics advance, enabling scalable insights into biological age and chronic risks—market forces like exponential growth in digital health investments (e.g., similar backers for Serena Williams' other startups) amplify this.[2][3] It influences the ecosystem by democratizing functional medicine, traditionally elite, through affordable at-home tools, challenging incumbents and inspiring platforms like Orreco in performance optimization while expanding the $100B+ wellness sector.[2][4]
Lifeforce is positioned to scale toward its audacious goal of optimizing 5 million lives by 2030, leveraging funding for AI-enhanced data tools, expanded diagnostics, and peptide/hormone therapies amid booming longevity demand.[1][3] Trends like AI-driven biomarker tracking and mainstream adoption of biological age metrics will propel it, potentially evolving into a full-stack longevity OS with partnerships in wearables or employer wellness. As midlife redefinition gains traction, Lifeforce could redefine aging not as decline, but optimization—echoing its founding mission to empower clearer thinking, stronger feeling, and longer living through science.[1][4]
Lifeforce has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series A in May 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2023 | $12.0M Series A | AirAngels, Bold Capital Partners, Footprint Coalition, Lead Edge Capital, Lever VC, M13, Mucker Capital, Next Ventures, Picus Capital, Seaside Ventures, Sequoia Capital, Serena Ventures, TechSquare Labs, Vast Ventures, Willow Growth Partners LP, ZhenFund, Ron Pragides, Scott Belsky |
